Healthcare professionals will aim to reduce the number of tools used to ensure the interoperability of software solutions for their patients, meaning there may be a merger of technologies focused on specific pathologies.

What makes your technology or solution unique compared to other offerings in the market?

At Stēto, we are convinced that digital health will only become mainstream if it is seen as complementary to traditional, personal care — not as a replacement. Remote monitoring is a prime example of correlating digital and in-person care, as it can be developed either as a standalone, fully digital tool or as a hybrid approach that includes personal intervention. Our product combines monitoring software with regular personal touchpoints by qualified healthcare professionals.

How are you integrating AI into your existing digital health solutions, and what benefits are you seeing?

Diabetes-related devices generate a significant amount of data, including continuous blood sugar monitoring and insulin doses. Given the number of patients managed by medical teams, the volume of data far exceeds what can reasonably be analyzed. This issue is growing as more patients are equipped with continuous monitoring devices and insulin pumps, which generate much more data than traditional devices. At Stēto, we see the primary role of artificial intelligence (AI) as to reduce this data to its most relevant aspects, making it digestible for medical teams. We believe AI should act as an initial data filter, followed by human analysis, allowing clinicians to focus on concise, meaningful, and actionable data for straightforward clinical interpretation.

Can you talk about any strategic partnerships you have formed and how they are helping to advance your goals in digital health?

In line with our vision of a hybrid-support program, we have partnered with the French-speaking Diabetes Nurses Association, a network of expert diabetes nurses across the country. These healthcare professionals receive extensive training in diabetes management, including knowledge of medication, devices, and treatment strategies. Through this partnership, we offer high-level monitoring support to patients and practitioners on our platform, ensuring that every patient, regardless of their distance from healthcare centers, can access the best treatment options. Diabetes is a complex condition,  one of the few conditions where patients must manage a drug daily, with dosing errors potentially leading to serious consequences. Patient training and information are key success factors and with rapid innovation in diabetes devices, support from trained specialists is critical.

What strategies are you using to engage patients and healthcare providers in using your digital health solutions?

Engagement is a central metric in digital health. We understand that beyond the platform we offer, the overall experience drives user satisfaction and engagement. Along with healthcare professionals, we view technology and software as supportive tools, not the end goal. Therefore, we focus on an engagement pathway to ensure that using our solution is enjoyable and leads to value creation. Our holistic approach to engagement is a key factor in our growth, which extends beyond in-app engagement to include merchandising, interpersonal relationship-building, and a clear strategical system of goals and rewards.

What are the most significant technology trends you see shaping the industry over the next few years and how is your company leveraging these trends to maintain a leading position?

We expect — following active development of emerging entrepreneurial projects and public insurance-related reimbursement to promote patient use — that remote monitoring will enter a consolidation phase. Healthcare professionals will aim to reduce the number of tools used to ensure the interoperability of software solutions for their patients, meaning there may be a merger of technologies focused on specific pathologies. We also believe AI will play a significant role in managing patient data, enhancing the capacity of medical teams to monitor large patient populations.

What changes / improvements would you like to see in the regulatory space to support the growth / sustainability of the industry?

In a globalized economy, a uniform legal framework is critical to ensuring a high-quality standard for patients worldwide. In 2021, the European Commission reinforced regulatory requirements for medical device providers through the Medical Device Regulation (EU) 2017/745. Additionally the interpretation of this regulation continues to evolve through the publication of Medical Device Coordination Group (MDCG) reports. Software as a Medical Device (SaMD) is a very specific segment of medical devices, and therefore it is essential that future regulations account for the frequent updating specificities of the software to prevent them from hindering the development of new software solutions.